Ensures compliance with internationally recognized guidelines outlined by the World Health Organization for Good Manufacturing Practices, as applicable to Active Pharmaceutical Ingredients (APIs). This certification governs the implementation of validated analytical methods, stringent quality management systems (QMS), and continuous process monitoring to ensure batch consistency, traceability, and compliance with pharmacopeial standards (e.g., USP, Ph. Eur.).
It guarantees that all operations, including sampling, testing, and release, are performed under controlled conditions, meeting regulatory requirements for pharmaceutical-grade cannabinoid production and facilitating market access in jurisdictions requiring GMP-compliant Pharmaceutical Quality APIs.
Provides the FDA framework for Good Manufacturing Practices for Finished Pharmaceuticals. We follow these regulations to ensure that our finished CBD products are manufactured, processed, and packaged in ways that guarantee quality, purity, and safety.
Process Validation: We ensure that every phase of production is thoroughly validated, and we maintain strict documentation at every step.
In-Process and Final Product Testing: Our in-process controls and final product tests are designed to ensure that our products meet all required standards before they are released to the market.
Designed to ensure the consistent quality and safety of Active Pharmaceutical Ingredients (APIs).
Material Management: We strictly control our raw materials, intermediates, and APIs throughout the manufacturing process.
Process Validation: Detailed IQ/OQ/PQ protocols for all equipment, ongoing process monitoring.
Documentation and Change Control: All documentation, including batch records and SOPs, is managed through our eQMS
Contamination Control: We use cleanrooms with HEPA filtration and strict gowning procedures
Audits and Inspections: We conduct regular internal and external audits
An internationally recognized framework that harmonizes GMP standards between regulatory authorities. Our commitment to PIC/S Guide to GMP (PE 009-15) ensures that our operations are globally compliant.
Batch Traceability: Every batch is fully traceable from raw material intake through to the final product. This is vital for recalls or investigations in the case of quality deviations.
Quality Risk Management: Our approach incorporates risk-based assessments, from supplier management to process validation and in-process controls
Personnel Training and Qualification: All training records are meticulously maintained within our eQMS, and we regularly assess staff to ensure ongoing compliance.
(in progress)
I can answer the most common questions from all of the quality audits we see here at Vantage Hemp. While I am not meant to replace a live engagement with our QA team, I can accelerate your early stage qualification process.
Please note,I’m not great at figuring out check boxes, symbols, and tables within tables. For best results, save your questionnaire as a text file before uploading. MS Word documents should be saved as .txt with encoding for best results.
In developing novel drugs for novel indications, pharmaceutical companies and drug developers must have faith that their API provider and contract manufacturer can stay with them for the long haul. Vantage invests in world-class pharmaceutical manufacturing capabilities with a long-term view toward the CBD market.
View our case study Formulation Development and cGMP Clinical Batch Manufacturing to learn more.
Work with Vantage Hemp to support your investigational new drug, clinical trial, and commercialization needs. Our team of experts has deep experience in pharmaceutical manufacturing and the journey from IND to commercialization. We understand the R&D and clinical trial process as you work through your drug development cycles.
Team Formation
Project Governance
Workstreams: Regulatory and Commercial
Kick-off Meetings
Project Monitoring and Reporting
Pre-formulation and formulation development using client cGMP SOPs
Development of novel cGMP SOPs as required by client or regulator
Manufacture, release, and perform stability testing for cGMP placebo clinical batch
Manufacture, release, and perform stability testing for cGMP active clinical batch
Phased studies – clinical batch planning, manufacturing planning (includes active and placebo), and distribution (finish & fill) support
Demand planning and scaling for full commercialization
Formulation Development
Product Development
Materials Sourcing
Clinical Product and Finished Product Manufacturing
Release and Testing of Pre-clinical and Clinical Supplies
Support all required DEA requests, drug substance quantities, laboratory activity reports
Support regulatory filings for FDA, NIH, other bodies
Conduct solubility and stability evaluations of the required APIs
Identify excipient classes and conduct as needed compatibility screening
Perform drug solubility testing and analysis
Pharmaceutical Grade CBD products are created and tested in a laboratory setting to meet the compliance standards of the pharmaceutical industry. These include WHO GMP, FDA 21 CFR 210/211, and ICH Q7. Additionally, Vantage Hemp’s submission of a Drug Master File (DMF) to the US FDA indicates that all of Vantage’s products are manufactured using high-quality ingredients and under strict guidelines for purity, safety, and efficacy.
Anyone who manufactures, tests, or packs pharmaceuticals or active pharmaceutical ingredients (APIs) must follow strict quality standards set forth by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Q7 lays out these quality standards for Good Manufacturing Practices in the pharmaceutical industry. To obtain ICH Q7 certification, a company must pass a rigorous audit of its facilities, equipment, personnel, and quality control procedures.
Current Good Manufacturing Practices (cGMP) is a product safety protocol that companies must follow during the CBD manufacturing process. cGMP CBD products are formulated in a way that human error is eliminated and the ingredients used have been tested, examined, and properly processed to create a finished product. cGMP ensures current innovation processes and production methods follow established scientific standards for data capture, data analysis, record keeping, and product labeling – and are constantly updated to the highest global standards.
WHO GMP (World Health Organization – Good Manufacturing Practices) and FDA 21 CFR 210/211 (Food and Drug Administration Code of Federal Regulations Title 21) are guidelines that provide a framework for manufacturing quality pharmaceutical products. WHO GMP covers all aspects of production from raw materials used across the supply chain to the packaging and labeling of finished products on pharmacy shelves. Most countries have adopted WHO GMP as the gold standard in pharmaceutical manufacturing with FDA CFR 210/211 and ICH Q7.